3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
5
Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Endometrial Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Prostatic Neoplasms
1
Prostate Cancer Recurrent
1
Posterior Fossa Ependymal Tumor
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms by Site
1
Metabolic Diseases
1
Insulin Resistance
1
Infertility
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Drug-drug Interaction,SHR3680
1
Diabetes Mellitus, Type 2
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Breast Diseases
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
pertuzumab
2
Trastuzumab
2
Taxes
2
Standard of Care
2
Practice Guidelines as Topic
2
Paclitaxel
2
High-Energy Shock Waves
2
Docetaxel
2
trastuzumab biosimilar HLX02
1
Transcutaneous Electric Nerve Stimulation
1
Specimen Handling
1
Radiation Dose Hypofractionation
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Minoxidil
1
Methods
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Educational Status
1
Early Intervention, Educational
1
Disulfides
1
Carboplatin
1
Biopsy
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage I Breast Cancer AJCC v8
×
Metformin
×
30 days
×
Clear all
No trials found.